Ayman S Bannaga
Overview
Explore the profile of Ayman S Bannaga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tyagi H, Daulton E, Bannaga A, Arasaradnam R, Covington J
Biosensors (Basel)
. 2021 Nov;
11(11).
PMID: 34821653
Bladder cancer (BCa) and prostate cancer (PCa) are some of the most common cancers in the world. In both BCa and PCa, the diagnosis is often confirmed with an invasive...
2.
Tyagi H, Daulton E, Bannaga A, Arasaradnam R, Covington J
Sensors (Basel)
. 2021 Aug;
21(16).
PMID: 34450881
Electronic noses (e-nose) offer potential for the detection of cancer in its early stages. The ability to analyse samples in real time, at a low cost, applying easy-to-use and portable...
3.
Bannaga A, Alvarez R, Zhou L, Petchey M, Noufaily A, Hitchins M, et al.
HPB (Oxford)
. 2021 May;
23(10):1595-1606.
PMID: 33931320
Background: Methylated septin 9 (mSEPT9) has a role in hepatocarcinogenesis. We evaluated mSEPT9 performance in patients with hepatocellular carcinoma (HCC) and those at risk of HCC METHODS: Using Epi-proColon® V2.0...
4.
Bannaga A, Tyagi H, Daulton E, Covington J, Arasaradnam R
Molecules
. 2021 Apr;
26(9).
PMID: 33922256
Hepatocellular carcinoma (HCC) biomarkers are lacking in clinical practice. We therefore explored the pattern and composition of urinary volatile organic compounds (VOCs) in HCC patients. This was done in order...
5.
Bannaga A, Metzger J, Kyrou I, Voigtlander T, Book T, Melgarejo J, et al.
EBioMedicine
. 2020 Nov;
62:103083.
PMID: 33160210
Background: Liver fibrosis is a consequence of chronic inflammation and is associated with protein changes within the hepatocytes structure. In this study, we aimed to investigate if this is reflected...
6.
Bannaga A, Kvasnik F, Persaud K, Arasaradnam R
J Breath Res
. 2020 Oct;
15(1):017102.
PMID: 33086204
Background: In the human body, volatile organic compounds (VOCs) are produced by different tissues then secreted in different body fluids and subsequently excreted. Here we explore a non-invasive method for...
7.
Bannaga A, Tabuso M, Farrugia A, Chandrapalan S, Somal K, Lim V, et al.
Clin Med (Lond)
. 2020 Sep;
20(5):463-467.
PMID: 32934038
Objective: The objective was to study hospitalised COVID-19 patients' mortality and intensive care unit (ICU) admission with covariates of interest (age, gender, ethnicity, clinical presentation, comorbidities and admission laboratory findings)....
8.
Wright H, Bannaga A, Iriarte R, Mahmoud M, Arasaradnam R
Pediatr Res
. 2020 Mar;
89(2):263-268.
PMID: 32120380
Background: Volatile organic compounds (VOCs) are hydrocarbons that originate within different healthy and diseased tissues. VOCs can be secreted into the circulation and then excreted in the urine and faeces....
9.
Bannaga A, Farrugia A, Arasaradnam R
Expert Rev Gastroenterol Hepatol
. 2019 Oct;
13(11):1113-1122.
PMID: 31657950
: Inflammatory bowel disease (IBD) is a common disease with significant morbidity. Noninvasive diagnostic techniques are lacking in IBD. Currently, fecal calprotectin is a sensitive marker of gut inflammation however...
10.
Bannaga A, Selinger C
Clin Exp Gastroenterol
. 2015 Apr;
8:111-7.
PMID: 25848313
Inflammatory bowel disease (IBD) causes severe physical symptoms and is also associated with psychological comorbidities. Abnormal anxiety levels are found in up to 40% of patients with IBD. Anxiety symptoms...